Abstract
Reducing COVID-19 illness and mortality for populations in the future will require equitable and effective risk-based allocations of scarce preventive resources, including early available vaccines. To aid in this effort, we develop a risk calculator for COVID-19 mortality based on various socio-demographic factors and pre-existing conditions for the US adult population by combining information from the UK-based OpenSAFELY study, with mortality rates by age and ethnicity available across US states. We tailor the tool to produce absolute risks for individuals in future time frames by incorporating information on pandemic dynamics at the community level as available from forecasting models. We apply this risk calculation model to available data on prevalence and co-occurrences of the risk-factors from a variety of data sources to project risk for the general adult population across 477 US cities (defined as Census Places) and for the 65 years and older Medicare population across 3,113 US counties, respectively. Validation analyses based on these projected risks and data on tens of thousands of recent deaths show that the model is well calibrated for the US population. Projections show that the model can identify relatively small fractions of the population (e.g. 4.3%) which will lead to a disproportionately large number of deaths (e.g. 49.8%), and thus will be useful for effectively targeting individuals for early vaccinations, but there will be wide variation in risk distribution across US communities. We provide a web-based tool for individualized risk calculations and interactive maps for viewing the city-, county- and state-level risk projections.
Competing Interest Statement
E.W. is an employee of the business corporation PolicyMap Corp. She has not been involved in the design or analysis of the study. She has created the maps with PolicyMap mapping tools with the data provided to her. She has reviewed and commented on the final manuscript.
Funding Statement
The funding for this research came from the Bloomberg Distinguished Professorship endowment of Dr. Nilanjan Chatterjee.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The IRB and ethics committee approvals are exempted because our project does not involve human subject research and it only involves the analysis of publicly available anonymizes data.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Manuscript revised; author list updated; supplementary files updated.
Data Availability
All data used in the manuscript are publically available and can be accessed at https://github.com/nchatterjeelab/COVID19Risk/tree/master/data. All codes for data management and analysis can be accessed at https://github.com/nchatterjeelab/COVID19Risk.
https://github.com/nchatterjeelab/COVID19Risk/tree/master/data
